The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network meta-analysis of 58 randomized controlled trials Juan LingPeng ChengKe-hu Yang Review Article 21 September 2018 Pages: 249 - 272
Soluble ST2 is a biomarker for cardiovascular mortality related to abnormal glucose metabolism in high-risk subjects Marina CardelliniStefano RizzaMassimo Federici Original Article 26 September 2018 Pages: 273 - 280
Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young Xiaojing WangTong WangXinhua Xiao Original Article 06 October 2018 Pages: 281 - 288
Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis Giulio MarchesiniPatrizio PasqualettiGiorgio Zanette Original Article 10 October 2018 Pages: 289 - 299
Transient neonatal diabetes mellitus and hypomethylation at additional imprinted loci: novel ZFP57 mutation and review on the literature Ameni TouatiJavier Errea-DorronsoroDorra H’mida ben brahim Original Article 13 October 2018 Pages: 301 - 307
Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L Mitsuyoshi TakaharaNaoto KatakamiIichiro Shimomura Original Article 23 October 2018 Pages: 309 - 319
High intensity interval training protects the heart during increased metabolic demand in patients with type 2 diabetes: a randomised controlled trial Jose SuryanegaraSophie CassidyDjordje G. Jakovljevic Original Article Open access 01 November 2018 Pages: 321 - 329
Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis Lorenzo M. VetroneFrancesco ZaccardiKamlesh Khunti Original Article Open access 19 November 2018 Pages: 331 - 339
The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis Carla CarnovaleMarco PozziPaolo Fiorina Original Article 26 November 2018 Pages: 341 - 354
Effectiveness of insulin glargine U-300 versus insulin glargine U-100 on nocturnal hypoglycemia and glycemic control in type 1 and type 2 diabetes: a systematic review and meta-analysis Ana Díez-FernándezIván Cavero-RedondoVicente Martínez-Vizcaíno Original Article 03 December 2018 Pages: 355 - 364
A novel role of bone morphogenetic protein 6 (BMP6) in glucose homeostasis Martina PaukTatjana Bordukalo-NiksicSlobodan Vukicevic Original Article Open access 11 December 2018 Pages: 365 - 371
Comparison of correlations of equation-derived body fat percentage and body mass index with carotid intima-media thickness Manuel Fortún LandechoInmaculada ColinaÓscar Beloqui Short Communication 23 November 2018 Pages: 373 - 375
Fulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability? Lucien MarchandSophie ReffetCharles Thivolet Short Communication 01 December 2018 Pages: 377 - 378
Glucose variability in PD-1 inhibitors-induced diabetes mellitus Francesco TassoneElena Gamarra Letter to the Editor 01 December 2018 Pages: 379 - 380
Serum bilirubin concentrations, type 2 diabetes and incident coronary heart disease Tomoyuki Kawada Letter to the Editor 22 November 2018 Pages: 381 - 382
Reply to comment: Serum bilirubin concentrations, type 2 diabetes, and incident coronary heart disease Jing WangXiaofen WuMeian He Letter to the Editor 22 November 2018 Pages: 383 - 384